Félix Javier Jiménez-Jiménez Selected Research

Félix Javier Jiménez-Jiménez Research Topics

Disease

20	Parkinson Disease (Parkinson's Disease) 07/2023 - 05/2002
15	Migraine Disorders (Migraine) 03/2024 - 09/2005
12	Essential Tremor (Essential Tremors) 06/2022 - 01/2006
12	Restless Legs Syndrome (Restless Legs) 01/2022 - 04/2013
9	Tremor (Tremors) 01/2020 - 01/2006
6	Multiple Sclerosis 11/2020 - 09/2010
4	Epilepsy (Aura) 01/2023 - 07/2017
3	Parkinsonian Disorders (Parkinsonism) 06/2022 - 05/2002
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2016 - 01/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2023 - 06/2022
2	Synucleinopathies 01/2023 - 11/2021
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 06/2022 - 03/2013
2	Lewy Body Disease (Lewy Body Dementia) 06/2022 - 08/2021
2	Multiple System Atrophy 06/2022 - 03/2013
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 07/2008
2	Inflammation (Inflammations) 11/2020 - 01/2016
2	Movement Disorders (Movement Disorder) 04/2013 - 01/2008
2	Ataxia (Dyssynergia) 01/2013 - 02/2011
2	Blepharospasm 11/2006 - 07/2006
2	Migraine without Aura (Common Migraine) 05/2006 - 09/2005
2	Myoclonus (Nocturnal Myoclonus) 05/2006 - 01/2004
1	Migraine with Aura (Familial Hemiplegic Migraine) 03/2024
1	Parasomnias (Parasomnia) 07/2023
1	Chorea (Rheumatic Chorea) 07/2023
1	Sleep Wake Disorders 07/2023
1	Neuroacanthocytosis 07/2023
1	Cognitive Dysfunction 02/2023
1	Dementia (Dementias) 02/2023
1	Alzheimer Disease (Alzheimer's Disease) 02/2023
1	Nervous System Diseases (Neurological Disorders) 06/2022
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2021
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2021
1	Polyneuropathies (Polyneuropathy) 01/2021
1	COVID-19 11/2020
1	Sepsis (Septicemia) 11/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2020
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2020
1	Chronic Hepatitis C 11/2020
1	Neuroinflammatory Diseases 11/2020
1	Sleepiness 01/2020
1	Tourette Syndrome (Tourette's Syndrome) 01/2019

Drug/Important Bio-Agent (IBA)

8	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2024 - 06/2015
8	Ethanol (Ethyl Alcohol)IBA 10/2023 - 07/2007
7	EnzymesIBA 03/2024 - 01/2008
7	Histamine (Histamine Dihydrochloride)FDA Link 06/2022 - 01/2008
6	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2023 - 01/2013
5	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2013
5	gamma-Aminobutyric Acid (GABA)IBA 01/2018 - 02/2011
4	Carrier Proteins (Binding Protein)IBA 10/2023 - 04/2021
4	Vitamin D FDA LinkGeneric 10/2023 - 01/2013
4	GABA Receptors (GABA Receptor)IBA 01/2018 - 02/2011
3	AcidsIBA 03/2024 - 07/2017
3	coenzyme Q10 (CoQ10)IBA 02/2023 - 10/2010
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2016
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2021 - 01/2020
3	mesoglycanIBA 01/2021 - 07/2016
3	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 02/2019 - 07/2007
3	TransferasesIBA 01/2017 - 10/2008
3	Topiramate (Topamax)FDA LinkGeneric 07/2008 - 05/2006
2	NucleotidesIBA 10/2023 - 11/2022
2	Vitamin D-Binding ProteinIBA 10/2023 - 06/2022
2	25-hydroxyvitamin DIBA 10/2023 - 04/2021
2	Dopamine Agonists (Dopamine Agonist)IBA 07/2023 - 05/2002
2	SynucleinsIBA 11/2022 - 01/2019
2	Amine Oxidase (Copper-Containing)IBA 06/2022 - 02/2015
2	IronIBA 01/2021 - 01/2007
2	Heme (Haem)IBA 05/2017 - 02/2016
2	Histamine N-MethyltransferaseIBA 07/2016 - 01/2008
2	Heme Oxygenase-1IBA 02/2016 - 08/2015
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 10/2015 - 06/2015
2	Glutamic Acid (Glutamate)FDA Link 03/2014 - 02/2014
2	ropinirole (Requip)FDA LinkGeneric 07/2013 - 07/2009
2	Dopamine D3 ReceptorsIBA 04/2013 - 10/2009
2	Aryldialkylphosphatase (Paraoxonase)IBA 09/2010 - 09/2010
2	Antidepressive Agents (Antidepressants)IBA 03/2009 - 01/2004
2	Gabapentin (Neurontin)FDA LinkGeneric 07/2008 - 05/2007
2	Primidone (Sertan)FDA LinkGeneric 07/2008 - 01/2006
2	Levodopa (L Dopa)FDA LinkGeneric 01/2004 - 05/2002
1	AntioxidantsIBA 03/2024
1	thiobarbituric acidIBA 03/2024
1	Thiobarbituric Acid Reactive SubstancesIBA 03/2024
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 03/2024
1	AntibodiesIBA 07/2023
1	Therapeutic UsesIBA 02/2023
1	Neuroprotective AgentsIBA 02/2023
1	LigandsIBA 11/2022
1	Trace Elements (Biometals)IBA 01/2022
1	ZincIBA 01/2022
1	alpha-SynucleinIBA 08/2021
1	Genetic Markers (Genetic Marker)IBA 05/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Amantadine (Aman)FDA LinkGeneric 11/2020
1	LipopolysaccharidesIBA 11/2020
1	Memantine (Namenda)FDA Link 11/2020
1	Cannabinoid Receptor AntagonistsIBA 01/2020
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2020
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2020
1	HarmalineIBA 01/2020

Therapy/Procedure

14	Therapeutics 03/2024 - 05/2002
2	Drug Therapy (Chemotherapy) 07/2023 - 05/2002